SCHEMBL3142849

SCHEMBL3142849

CCCCN1C(=O)CC(=O)N(CCCCCO)C1=S

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.42
MEN1 O00255 4/20 0.40
KMT2A Q03164 4/20 0.40
GAA P10253 3/20 0.40
MGLL Q99685 5/20 0.40
PTGS1 P23219 3/20 0.40
PTGS2 P35354 3/20 0.40
FAAH O00519 3/20 0.40
ALDH1A1 P00352 4/20 0.38
LMNA P02545 3/20 0.38
HSD17B10 Q99714 1/20 0.38
TSHR P16473 1/20 0.38
SMN1; SMN2 Q16637 4/20 0.37
NPC1 O15118 2/20 0.37
RAB9A P51151 2/20 0.37
RECQL P46063 2/20 0.37
HTT P42858 2/20 0.37
RGS12 O14924 1/20 0.37
PABPC1 P11940 1/20 0.37
MAPT P10636 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12101786 0.88 MGLL (0.46) KDM4EMEN1KMT2AGAAMGLL
SCHEMBL5570285 0.88 MGLL (0.50) KDM4EMEN1KMT2AGAAMGLL
SCHEMBL145408 0.88 KDM4E (0.46) KDM4EMEN1KMT2AGAAMGLL
SCHEMBL8652814 0.86 MGLL (0.47) KDM4EMEN1KMT2AGAAMGLL
SCHEMBL3142469 0.84 MGLL (0.40) KDM4EMEN1KMT2AGAAMGLL
SCHEMBL11868886 0.80 KDM4E (0.43) KDM4EMEN1KMT2AGAAMGLL
SCHEMBL4859026 0.80 KDM4E (0.46) KDM4EMEN1KMT2AGAAMGLL
SCHEMBL24682259 0.77 KMT2A (0.45) KDM4EMEN1KMT2AGAAPTGS1
SCHEMBL8338673 0.77 MAPT (0.47) KDM4EMEN1KMT2AGAAMGLL
SCHEMBL24683243 0.77 KMT2A (0.35) KDM4EMEN1KMT2AGAAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7687282-B2 Detection of transmembrane potentials by optical methods THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2010-03-30 US disclosed
US-20070026384-A1 Detection of transmembrane potentials by optical methods THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2007-02-01 US disclosed
US-7115401-B2 Detection of transmembrane potentials by optical methods THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2006-10-03 US disclosed
EP-0834074-B2 DETECTION OF TRANSMEMBRANE POTENTIALS BY OPTICAL METHODS UNIV CALIFORNIA (US) 2005-11-16 EP disclosed
US-6342379-B1 Detection of transmembrane potentials by optical methods THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2002-01-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070026384-A1 Detection of transmembrane potentials by optical methods MBOAT1, TRPM4, NME4 KDM4E 4599/4885MEN1 1020/4885KMT2A 4397/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.